Fortune lauded Cipla for “driving prices down for much-needed medications
Cipla have been recognised by Fortune magazine in a list of global firms changing the world for the good and having a positive social impact through their activities. Cipla is ranked 46th in the list of 50 followed by Godrej on the 48th spot, the only Indian companies in the list. The list has been topped by British pharma giant GlaxoSmithKline.
The Fortune 2016 ‘Change the World’ list recognises companies that have had a positive social impact through activities that are part of their core business strategy.
Fortune lauded Cipla for “driving prices down for much-needed medications.”
“Cipla has made affordability and global accessibility to medicines the cornerstone of its business plan, reflecting the company’s vision (of) ‘None shall be denied’,” it said.
It added that Cipla has by far the world’s widest range of antiretroviral (ARV) products approved by Food and Drug Administration and World Health Organisation for treating both children and adults suffering from HIV/AIDS, and also offers free ARV technology to all African countries wanting to produce their own drugs.
On Cipla’s horizon is low-cost pills to fight cancer. The company is investing in a drive to create “biosimilar” versions of certain pricey oncology drugs. “Expect heated intellectual-property debates-and cheaper medicines,” it said.